IID, Inc.
IID, Inc. (6038.T) Financial Performance & Income Statement Overview
Explore the financials of IID, Inc. (6038.T), including yearly and quarterly data on income, cash flow, and balance sheets.
IID, Inc. (6038.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for IID, Inc. 6038.T financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.58B | $1.50B | $1.47B | $1.63B |
| Cost of Revenue | $846.00M | $787.00M | $815.78M | $869.85M |
| Gross Profit | $732.00M | $712.00M | $654.58M | $757.39M |
| Gross Profit Ratio | $0.46 | $0.47 | $0.45 | $0.47 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $561.00M | $543.00M | $623.40M | $537.00M |
| Operating Expenses | $557.00M | $548.00M | $623.40M | $537.05M |
| Total Costs & Expenses | $1.40B | $1.33B | $1.44B | $1.41B |
| Interest Income | $0.00 | $0.00 | $644000.00 | $765000.00 |
| Interest Expense | $0.00 | $0.00 | $981000.00 | $723000.00 |
| Depreciation & Amortization | $36.50M | $38.50M | -$145.09M | $2.56M |
| EBITDA | $207.50M | $207.50M | -$113.91M | $222.91M |
| EBITDA Ratio | $0.13 | $0.14 | -$0.08 | $0.14 |
| Operating Income | $175.00M | $164.00M | $31.18M | $220.34M |
| Operating Income Ratio | $0.11 | $0.11 | $0.02 | $0.14 |
| Other Income/Expenses (Net) | -$5.00M | -$3.00M | -$191.96M | $16.52M |
| Income Before Tax | $170.00M | $161.00M | -$160.78M | $236.86M |
| Income Before Tax Ratio | $0.11 | $0.11 | -$0.11 | $0.15 |
| Income Tax Expense | $54.00M | $69.00M | -$27.52M | $92.00M |
| Net Income | $112.00M | $91.00M | -$127.37M | $141.93M |
| Net Income Ratio | $0.07 | $0.06 | -$0.09 | $0.09 |
| EPS | $22.56 | $18.53 | -$26.02 | $28.97 |
| Diluted EPS | $22.56 | $18.53 | -$25.97 | $28.85 |
| Weighted Avg Shares Outstanding | $4.96M | $4.91M | $4.89M | $4.92M |
| Weighted Avg Shares Outstanding (Diluted) | $4.97M | $4.91M | $4.90M | $4.90M |
The company's financials show resilient growth, with revenue advancing from $1.63B in Q3 2024 to $1.58B in Q2 2025. Gross profit remained healthy with margins at 46% in Q2 2025 compared to 47% in Q3 2024. Operating income hit $175.00M last quarter, sustaining a consistent 11% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $207.50M. Net income rose to $112.00M, while earnings per share reached $22.56. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan